Cross-cancer comparative analyses further indicate that HCC TANs show unique metabolic programming, characterised by upregulation of glycolytic genes (HK2, PFKP) and fatty acid oxidation genes (carnitine palmitoyltransferase 1A[CPT1A]). This evidence concerns the gene CPT1A and hepatocellular carcinoma.